Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Launched by CHROMX HEALTH · Jul 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to diagnose various lung diseases by analyzing the gases we breathe out. Researchers are developing a special computer program, powered by artificial intelligence, that looks at specific markers in exhaled breath to identify conditions like lung cancer, COPD, and asthma. The goal is to see how accurately this method can diagnose these diseases compared to traditional methods.

To participate in the trial, you need to be at least 18 years old and have a confirmed lung disease based on CT imaging. You should also be able to share your CT images with the research team and be willing to sign a consent form. Unfortunately, individuals who are pregnant, have other severe illnesses, or a history of cancers other than lung disease cannot join. If you qualify, you’ll be part of a study that could lead to better diagnosis methods for lung diseases, using a simple breath test instead of more invasive procedures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Males or females, age must be 18 years old or above.
• • Patients must meet the CT imaging diagnostic criteria for different lung diseases, and patients must be able to provide electronic versions of CT image data.
• • Patients must have a clear clinical diagnosis.
• • All participants must sign a written informed consent form.
• Exclusion Criteria:
• • Pregnant women.
• • Individuals with a history of cancer other than lung disease.
• • Individuals who have undergone organ transplants or non-autologous (allogeneic) bone marrow or stem cell transplants.
• • Individuals with other severe organic diseases or mental illnesses.
• • Individuals with metabolic diseases such as diabetes, hyperlipidemia, etc.
• • Any other condition that researchers deem unsuitable for participation in this clinical trial.